Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose for chronic fatigue in non-anemic IBD patients with iron deficiency
2011-002122-43Phase 2Active
- Sponsor
- Humanitas Research Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA) and asthenia, sponsored by Humanitas Research Hospital. Primary endpoint: Chronic fatigue remission. Started Mar 2012; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)asthenia
Beyond the preview
Go deeper on 2011-002122-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002122-43.